Long-term analysis of pulmonary hypertension and tricuspid regurgitation after transcatheter aortic valve replacement

Autor:	Dymitri Siqueira, D. Le Bihan, T. C Bignoto, Matheus Simonato, B. M. O Nascimento, Auristela Isabel de Oliveira Ramos, M. F. M Santos, Amanda G. M. R. Sousa, A. Abizaid, N Oliveira, Alexandre C. Souza, Rodrigo Bellio de Mattos Barretto, P. C. C Sousa
Rok vydání:	2020
Předmět:	medicine.medical_specialty Valve replacement Transcatheter aortic business.industry Internal medicine medicine.medical_treatment medicine Cardiology Regurgitation (circulation) Cardiology and Cardiovascular Medicine business medicine.disease Pulmonary hypertension
Zdroj:	European Heart Journal. 41
ISSN:	1522-9645 0195-668X
DOI:	10.1093/ehjci/ehaa946.1882
Popis:	Introduction Transcatheter aortic valve replacement (TAVR) is increasingly utilized in treatment of aortic stenosis (AS). AS is commonly associated to pulmonary hypertension (PH) and tricuspid regurgitation (TR). We aimed to evaluate the long-term post-TAVR course of PH and TR. Methods Patients undergoing TAVR were screened for 24-month echocardiographic data on PH and TR. All echocardiograms were performed by a single team. Patients were divided in groups according to TR and PH (pulmonary systolic pressure ≥ or Results 156 and 151 patients were selected for PH and TR follow-up, respectively. Mean follow-up was 42.23±17.53 months and 42.60±17.67 months for PH and TR groups. Maximum follow-up was 96 months. PH was reduced post-TAVR (32.7% pre-TAVR vs. 20.5% post-TAVR, p Conclusions TAVR was able to reduce the severity of PH, but not TR, in this cohort. Additionally, long-term survival was affected by PH, diastolic dysfunction and LA sizing. Kaplan-Meier survival curve Funding Acknowledgement Type of funding source: None
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c5bbd01186cbdffda48182f7bd0468ea https://doi.org/10.1093/ehjci/ehaa946.1882 Zobrazit plný text záznamu